Exact Mass: 607.1451592000001

Exact Mass Matches: 607.1451592000001

Found 11 metabolites which its exact mass value is equals to given mass value 607.1451592000001, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

({4-[(L-cystin-N2-yl)methylidene]-2-[1-(glycylamino)ethyl]-4,5-dihydro-5-oxo-1H-imidazol-1-yl}acetyl)-L-aspartic acid

({4-[(L-cystin-N2-yl)methylidene]-2-[1-(glycylamino)ethyl]-4,5-dihydro-5-oxo-1H-imidazol-1-yl}acetyl)-L-aspartic acid

C20H29N7O11S2 (607.1366404)


   

Telaglenastat hydrochloride

Telaglenastat hydrochloride

C26H25ClF3N7O3S (607.1380126)


C471 - Enzyme Inhibitor

   

Montelukast sodium

Montelukast sodium

C35H35ClNNaO3S (607.1923750000001)


D019141 - Respiratory System Agents > D018927 - Anti-Asthmatic Agents > D020024 - Leukotriene Antagonists D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006727 - Hormone Antagonists D065693 - Cytochrome P-450 Enzyme Inducers > D065694 - Cytochrome P-450 CYP1A2 Inducers COVID info from clinicaltrial, clinicaltrials, clinical trial, clinical trials C78273 - Agent Affecting Respiratory System > C29712 - Anti-asthmatic Agent Corona-virus Coronavirus SARS-CoV-2 COVID-19 SARS-CoV COVID19 SARS2 SARS

   

6-[2-(Oxylatosulfonyl)-4-(hydroxysulfonyl)phenyl]-3,4,8,9-tetrahydro-1,14:11,12-dipropano-2H,10H-1-azonia-11-aza-13-oxapentacene

6-[2-(Oxylatosulfonyl)-4-(hydroxysulfonyl)phenyl]-3,4,8,9-tetrahydro-1,14:11,12-dipropano-2H,10H-1-azonia-11-aza-13-oxapentacene

C31H31N2O7S2+ (607.1572596000001)


   

N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[2-[4-(trifluoromethyl)phenyl]ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide

N-[[(2R,3S)-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-8-[2-[4-(trifluoromethyl)phenyl]ethynyl]-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methyl-2-thiophenesulfonamide

C28H28F3N3O5S2 (607.1422394000001)


   

DS-1001b

DS-1001b

C29H29Cl3FN3O4 (607.1207575999999)


DS-1001b is an orally active, blood-brain permeable, potent IDH-1 (isocitrate dehydrogenase-1) mutant inhibitor. DS-1001b has antitumor activity[1][2][3].

   

6-methoxy-7-o-β-d-(4'-methoxy)glucopyrano-syl coumarin

NA

C31H27O13+ (607.1451592000001)


{"Ingredient_id": "HBIN012513","Ingredient_name": "6-methoxy-7-o-\u03b2-d-(4'-methoxy)glucopyrano-syl coumarin","Alias": "NA","Ingredient_formula": "C31H27O13+","Ingredient_Smile": "COC1=C(C=CC(=C1)C2=C(C=C3C(=CC(=CC3=[O+]2)O)O)OC4C(C(C(C(O4)COC5=CC6=CC=CC=C6OC5=O)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "13988","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}

   

(3s,6r,9s,12s,16r,18s)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-3,7,9,12,16,18-hexamethyl-14-methylidene-1-oxa-4,7,10-triazacyclooctadeca-4,10-diene-2,8,15-trione

(3s,6r,9s,12s,16r,18s)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-3,7,9,12,16,18-hexamethyl-14-methylidene-1-oxa-4,7,10-triazacyclooctadeca-4,10-diene-2,8,15-trione

C28H38BrN3O7 (607.1892978000001)


   

(3s,6s,9r,12s,16s,18r)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-3,7,9,12,16,18-hexamethyl-14-methylidene-1-oxa-4,7,10-triazacyclooctadeca-4,10-diene-2,8,15-trione

(3s,6s,9r,12s,16s,18r)-6-[(3-bromo-4-hydroxyphenyl)methyl]-5,11-dihydroxy-3,7,9,12,16,18-hexamethyl-14-methylidene-1-oxa-4,7,10-triazacyclooctadeca-4,10-diene-2,8,15-trione

C28H38BrN3O7 (607.1892978000001)